The majority of cases are diffuse large B-cell lymphomas (DLBCLs); however, within this classification, high-grade B-cell lymphomas (HGBLs) are distinguished based on specific genetic alterations (MYC, BCL2, and BCL6 translocations) and histological features [1]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.